BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30367380)

  • 1. Comparison of two dipyridamole infusion protocols for myocardial perfusion imaging in subjects with low likelihood of significant obstructive coronary artery disease.
    Harel F; Finnerty V; Authier S; Pelletier-Galarneau M
    J Nucl Cardiol; 2020 Oct; 27(5):1820-1828. PubMed ID: 30367380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of myocardial blood flow and flow reserve with dobutamine and dipyridamole stress using rubidium-82 positron emission tomography.
    Pelletier-Galarneau M; Ferro P; Patterson S; Ruddy TD; Beanlands RS; deKemp RA
    J Nucl Cardiol; 2021 Feb; 28(1):34-45. PubMed ID: 32449001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal Adenosine Stress for Maximum Stress Perfusion, Coronary Flow Reserve, and Pixel Distribution of Coronary Flow Capacity by Kolmogorov-Smirnov Analysis.
    Kitkungvan D; Lai D; Zhu H; Roby AE; Johnson NP; Steptoe DD; Patel MB; Kirkeeide R; Gould KL
    Circ Cardiovasc Imaging; 2017 Feb; 10(2):. PubMed ID: 28213449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine Clinical Quantitative Rest Stress Myocardial Perfusion for Managing Coronary Artery Disease: Clinical Relevance of Test-Retest Variability.
    Kitkungvan D; Johnson NP; Roby AE; Patel MB; Kirkeeide R; Gould KL
    JACC Cardiovasc Imaging; 2017 May; 10(5):565-577. PubMed ID: 28017383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consistent tracer administration profile improves test-retest repeatability of myocardial blood flow quantification with
    Klein R; Ocneanu A; Renaud JM; Ziadi MC; Beanlands RSB; deKemp RA
    J Nucl Cardiol; 2018 Jun; 25(3):929-941. PubMed ID: 27804067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial perfusion in patients with suspected coronary artery disease: comparison between 320-MDCT and rubidium-82 PET.
    Dantas RN; Assuncao AN; Marques IA; Fahel MG; Nomura CH; Avila LFR; Giorgi MCP; Soares J; Meneghetti JC; Parga JR
    Eur Radiol; 2018 Jun; 28(6):2665-2674. PubMed ID: 29352381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy.
    Bravo PE; Pozios I; Pinheiro A; Merrill J; Tsui BM; Wahl RL; Bengel FM; Abraham MR; Abraham TP
    Am J Cardiol; 2012 Oct; 110(7):1033-9. PubMed ID: 22748357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the myocardial blood flow response to regadenoson and dipyridamole: a quantitative analysis in patients referred for clinical 82Rb myocardial perfusion PET.
    Goudarzi B; Fukushima K; Bravo P; Merrill J; Bengel FM
    Eur J Nucl Med Mol Imaging; 2011 Oct; 38(10):1908-16. PubMed ID: 21656246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of treadmill exercise versus dipyridamole stress with myocardial perfusion imaging using rubidium-82 positron emission tomography.
    Chow BJ; Ananthasubramaniam K; dekemp RA; Dalipaj MM; Beanlands RS; Ruddy TD
    J Am Coll Cardiol; 2005 Apr; 45(8):1227-34. PubMed ID: 15837254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized Comparison of Clinical Effectiveness of Pharmacologic SPECT and PET MPI in Symptomatic CAD Patients.
    Patel KK; Al Badarin F; Chan PS; Spertus JA; Courter S; Kennedy KF; Case JA; McGhie AI; Heller GV; Bateman TM
    JACC Cardiovasc Imaging; 2019 Sep; 12(9):1821-1831. PubMed ID: 31326480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependency of cardiac rubidium-82 imaging quantitative measures on age, gender, vascular territory, and software in a cardiovascular normal population.
    Sunderland JJ; Pan XB; Declerck J; Menda Y
    J Nucl Cardiol; 2015 Feb; 22(1):72-84. PubMed ID: 25294436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological basis for angina and ST-segment change PET-verified thresholds of quantitative stress myocardial perfusion and coronary flow reserve.
    Johnson NP; Gould KL
    JACC Cardiovasc Imaging; 2011 Sep; 4(9):990-8. PubMed ID: 21920337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined evaluation of regional coronary artery calcium and myocardial perfusion by
    Zampella E; Acampa W; Assante R; Nappi C; Gaudieri V; Mainolfi CG; Green R; Cantoni V; Panico M; Klain M; Petretta M; Slomka PJ; Cuocolo A
    Eur J Nucl Med Mol Imaging; 2018 Apr; 45(4):521-529. PubMed ID: 29372272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computed tomography myocardial perfusion vs
    Williams MC; Mirsadraee S; Dweck MR; Weir NW; Fletcher A; Lucatelli C; MacGillivray T; Golay SK; Cruden NL; Henriksen PA; Uren N; McKillop G; Lima JA; Reid JH; van Beek EJ; Patel D; Newby DE
    Eur Radiol; 2017 Mar; 27(3):1114-1124. PubMed ID: 27334015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of PET-measured longitudinal flow gradient for the identification of coronary artery disease.
    Valenta I; Quercioli A; Schindler TH
    JACC Cardiovasc Imaging; 2014 Apr; 7(4):387-96. PubMed ID: 24631507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between gated myocardial perfusion SPECT findings and hemodynamic, electrocardiographic, and heart rate changes after Dipyridamole infusion.
    Gholoobi A; Ayati N; Baghyari A; Mouhebati M; Atar B; Dabbagh Kakhki VR
    Int J Cardiovasc Imaging; 2017 Jun; 33(6):951-956. PubMed ID: 28150082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regadenoson and adenosine are equivalent vasodilators and are superior than dipyridamole- a study of first pass quantitative perfusion cardiovascular magnetic resonance.
    Vasu S; Bandettini WP; Hsu LY; Kellman P; Leung S; Mancini C; Shanbhag SM; Wilson J; Booker OJ; Arai AE
    J Cardiovasc Magn Reson; 2013 Sep; 15(1):85. PubMed ID: 24063278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging.
    Farhad H; Dunet V; Bachelard K; Allenbach G; Kaufmann PA; Prior JO
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1203-10. PubMed ID: 23660750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left ventricular ejection fraction, myocardial blood flow and hemodynamic variables in adenosine and regadenoson vasodilator 82-Rubidium PET.
    Frey SM; Honegger U; Clerc OF; Caobelli F; Haaf P; Zellweger MJ
    J Nucl Cardiol; 2022 Jun; 29(3):921-933. PubMed ID: 34386864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative blood flow evaluation of vasodilation-stress compared with dobutamine-stress in patients with end-stage liver disease using
    Abele JT; Raubenheimer M; Bain VG; Wandzilak G; AlHulaimi N; Coulden R; deKemp RA; Klein R; Williams RG; Warshawski RS; Lalonde LD
    J Nucl Cardiol; 2020 Dec; 27(6):2048-2059. PubMed ID: 30456495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.